Stryker recently secured FDA clearance for its OptaBlate BVN system, aiming to enhance its portfolio in advanced pain therapy solutions. The company's share price rose 14% over the past month.

PORTAGE, Mich. - Stryker Corporation (NYSE:SYK), a $150 billion market cap leader in medical technology with annual revenues exceeding $23 billion, has announced the FDA 510(k) clearance of its ...

Stryker's first basivertebral nerve ablation system targets the basivertebral nerve to provide relief from chronic * vertebrogenic low back pain. "We often see patients with chronic low back pain ...

The health authority recently signed a deal worth about $531,000 with Vocera, a division of U.S.-based medical technology giant Stryker, for 158 hands-free wearable badges, along with the ability ...

The OptaBlate BVN nerve ablation system. [Images courtesy of Stryker] Stryker (NYSE: SYK) + announced today that it received FDA 510(k) clearance for its OptaBlate basivertebral nerve ablation ...

Belgium has dropped nuclear phaseout plans adopted over two decades ago. Previously, it had delayed the phaseout for 10 years over the energy uncertainty triggered by Russia's invasion of Ukraine ...